2500529 cohort 3 (IV)
Study for the treatment of influenza
18-65
- Male
- Female
< 7 days
2
1200
Are you
- a healthy man or woman
- between 18 and 65 years (inclusive)
- with a BMI between 18.5 and 32.0 kg/m² (inclusive)
- with a minimum body weight of 50.0 kg at screening
- who does not smoke or has stopped smoking at least 6 months prior to administration of the study medication
- nicotine-containing products (e.g., nicotine patches and e-cigarettes) must be stopped at least 6 months prior to administration of the study medication
- and does not use daily medication
What does this trial involve?
In study 2500529 (intravenous (IV)), SGS CPU is investigating the treatment of influenza. During +/- 5 weeks you will have the following appointments:
- a screening visit
- a stay consisting of 4 days (3 nights)
- 1 morning return visit
- an end of trial visit
Take part in this trial and
- contribute to the medicine of tomorrow
- a compensation will be provided
This study was approved by the competent Belgian health authorities and an independent ethics committee.
